Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cigna Corp
(NY:
CI
)
338.71
-0.55 (-0.16%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cigna Corp
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
Risk-Radar Alert: Analyst Acknowledges Cigna's Unrecognized Market Risk Hedge, Bestows Neutral Stance
April 21, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
April 21, 2023
Via
Benzinga
2 Top Healthcare Stocks to Buy Right Now
April 07, 2023
The demand for healthcare is positioned to steadily rise in the future.
Via
The Motley Fool
This Is What Whales Are Betting On Cigna Group
March 23, 2023
Via
Benzinga
A Bearish Sign Appears On Cigna Group's Chart
March 23, 2023
Via
Benzinga
Analyst Expectations for Cigna Group's Future
March 21, 2023
Via
Benzinga
10 Best Dividend Stocks to Buy Now in April
April 19, 2023
These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.
Via
The Motley Fool
7 Stocks That Hedge Funds Are Dumping Now
April 17, 2023
Everyone loves talking about what institutional players are buying. On the flipside, here’s a list of hedge fund stocks to avoid.
Via
InvestorPlace
How Rainbow ABA Therapy is Empowering Children with Autism through Personalized Treatment in Essex County
April 17, 2023
Via
GetFeatured
2 Reliable Dividend Stocks That Could Climb 24% to 32% According to Wall Street
April 08, 2023
New payment rates for Medicare Advantage plans bode well for these health benefits managers.
Via
The Motley Fool
Biden Admin Finalizes Rule To Crack Down Deceptive Medicare Advantage Advertising
April 06, 2023
Via
Benzinga
Peering Into Cigna Group's Recent Short Interest
March 13, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Cigna
February 07, 2023
Via
Benzinga
Cigna (CI) Q4 2022 Earnings Call Transcript
February 03, 2023
CI earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Cigna Q4 Results Beat Street View, Forecasts Higher FY23 Earnings, But Below Wall Street
February 03, 2023
Via
Benzinga
Why UnitedHealth Stock Was a Big Winner on Wednesday
April 05, 2023
A new, more bullish take on the company from a pundit attracted the right kind of investor attention.
Via
The Motley Fool
Cigna To Gain From Pharmacy Benefit Management Assets, Analyst Says, Upgrading The Stock To 'Strong Buy'
April 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
April 05, 2023
Via
Benzinga
Centers for Medicare & Medicaid Services Lowers Cut To Medicare Advantage Payments In 2024
April 03, 2023
The U.S. government announced on Friday a lower-than-expected 1.1% average cut of 2024 reimbursement rates for health insurers.
Via
Benzinga
Earnings Outlook For Cigna
February 02, 2023
Via
Benzinga
11 Stocks: 9 Dividend Payers 2 For Growth
March 30, 2023
Not all stocks are the same, and not all stocks serve the investor’s needs.
Via
Talk Markets
Does Big Pharmacy Managers Fix Prices? Ohio Attorney General Lawsuit Alleges Cigna, Humana Engaged In Price Fixing For Medicines
March 27, 2023
A lawsuit filed by the Ohio attorney general alleges that Cigna Corp (NYSE: CI), Humana Inc (NYSE: HUM), and Prime Therapeutics LLC shared pricing and other information to gain le
Via
Benzinga
Want to Get Richer? Buy This Blue Chip Dividend Stock and Don't Let Go
February 23, 2023
This managed care company serves hundreds of millions of customers.
Via
The Motley Fool
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
February 23, 2023
Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose...
Via
Benzinga
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
February 21, 2023
All three companies have shown consistent revenue and EPS growth.
Via
The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
February 03, 2023
The major indexes continued to run despite mixed-to-weak earnings.
Via
Investor's Business Daily
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
Trading in the U.S. index futures suggests stocks may end a solidly positive week on a negative note. That said, the data-dependency of the Fed places the onus of providing trading cues to each...
Via
Benzinga
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday
February 03, 2023
With Nasdaq stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Sharp Gains For Fourth Straight Week
February 03, 2023
The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors. US stocks closed mostly higher on Thursday, with the tech-laden Nasdaq index leading the rally. Investors...
Via
Benzinga
How Medicare Advantage Insurers Will Be Affected By Proposed 2024 Payment Cut
February 02, 2023
Medicare Advantage insurers might see an average 2.27% reduction in baseline payments in 2024, the Centers for Medicare and Medicaid Services said Wednesday.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.